Artificial Intelligence and Machine Learning in Diagnostics: A Comprehensive Review for Veterinary Medicine
1. Introduction
The integration of artificial intelligence (AI) and machine learning (ML) into diagnostic workflows represents a paradigm shift in veterinary medicine. These computational tools offer the potential to enhance diagnostic accuracy, reduce turnaround times, and uncover patterns imperceptible to human observers [1, 2]. The application of AI in diagnostics spans multiple modalities including medical imaging, molecular diagnostics, clinical pathology, and predictive modeling [3, 4]. This review provides a detailed examination of the biophysical and algorithmic principles underlying AI-driven diagnostics, with a focus on veterinary applications.
Machine learning algorithms, particularly deep learning architectures, have demonstrated remarkable performance in pattern recognition tasks across diverse biological datasets [5, 6]. Convolutional neural networks (CNNs) have become the standard architecture for image-based diagnostics, while recurrent neural networks and transformer models are increasingly applied to sequential data such as electrocardiograms and genomic sequences [7, 8]. The fundamental advantage of these approaches lies in their ability to learn hierarchical representations directly from raw data, bypassing the need for manual feature engineering [9, 10].
2. Fundamental Principles of Machine Learning in Diagnostics
2.1 Supervised and Unsupervised Learning Paradigms
Supervised learning remains the most widely applied paradigm in diagnostic AI, requiring labeled training data where each input sample is associated with a known outcome [11, 12]. Common supervised algorithms include support vector machines, random forests, gradient boosting machines, and deep neural networks [13, 14]. In veterinary diagnostics, supervised models have been trained to classify histopathological images, detect radiographic abnormalities, and predict disease outcomes from clinical parameters [15, 16].
Unsupervised learning methods, including clustering algorithms and autoencoders, are employed when labeled data are scarce or when the goal is to discover novel disease subtypes [17, 18]. These approaches have proven valuable in identifying previously unrecognized phenotypic clusters in complex diseases such as canine lymphoma and feline chronic kidney disease [19, 20]. Dimensionality reduction techniques, including principal component analysis and t-distributed stochastic neighbor embedding, facilitate visualization of high-dimensional diagnostic data [21, 22].
2.2 Deep Learning Architectures
Deep learning encompasses neural network architectures with multiple hidden layers that progressively extract higher-level features from input data [23, 24]. Convolutional neural networks (CNNs) utilize convolutional filters to detect spatial patterns, making them particularly suited for image analysis tasks [25, 26]. The architecture typically includes convolutional layers, pooling layers, and fully connected layers, with activation functions such as rectified linear units introducing nonlinearity [27, 28].
Recurrent neural networks (RNNs) and their variants, including long short-term memory (LSTM) networks and gated recurrent units (GRUs), are designed to process sequential data by maintaining internal states that capture temporal dependencies [29, 30]. These architectures have been applied to time-series data from continuous monitoring devices and to genomic sequence analysis [31, 32]. Transformer models, which rely on self-attention mechanisms rather than recurrence, have recently achieved state-of-the-art performance in many sequence-processing tasks [33, 34].
2.3 Training and Validation Considerations
The development of robust diagnostic AI models requires careful attention to dataset composition, annotation quality, and validation methodology [35, 36]. Training datasets must be sufficiently large and representative of the target population to avoid bias and ensure generalizability [37, 38]. Class imbalance, where certain disease conditions are underrepresented, can lead to models that perform poorly on minority classes [39, 40].
Cross-validation techniques, including k-fold cross-validation and stratified sampling, are essential for estimating model performance on unseen data [41, 42]. External validation using independent datasets from different institutions or geographic regions provides the strongest evidence of model robustness [43, 44]. Performance metrics including sensitivity, specificity, positive predictive value, negative predictive value, and area under the receiver operating characteristic curve (AUC-ROC) should be reported comprehensively [45, 46].
3. Applications in Veterinary Imaging Diagnostics
3.1 Radiography and Computed Tomography
AI-assisted interpretation of radiographic images has been extensively investigated in both human and veterinary medicine [47, 48]. Deep learning models have been developed to detect thoracic abnormalities including pulmonary nodules, cardiomegaly, and pleural effusion in canine and feline patients [49, 50]. The biophysical basis for these applications lies in the differential attenuation of X-rays by tissues of varying density, which produces characteristic patterns that CNNs can learn to recognize [51, 52].
Computed tomography (CT) imaging generates three-dimensional volumetric data that presents unique opportunities for AI analysis [53, 54]. Segmentation algorithms based on U-Net architectures can automatically delineate organs, tumors, and other structures of interest [55, 56]. Radiomics, the high-throughput extraction of quantitative features from medical images, combined with ML classifiers, has shown promise for characterizing lesions and predicting treatment responses [57, 58]. A systematic review of AI-based diagnosis models for pulmonary fibrosis demonstrated that deep learning approaches achieved AUC values exceeding 0.90 in multiple studies [41].
3.2 Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) provides exceptional soft tissue contrast and is widely used in veterinary neurology and orthopedics [59, 60]. AI models have been developed for automated segmentation of brain structures, detection of intervertebral disc herniation, and classification of intracranial neoplasms [61, 62]. Deep learning morphometric analysis on protocol biopsies has been shown to predict future graft function in renal transplant patients, demonstrating the potential for analogous applications in veterinary transplant medicine [94].
The integration of AI with MRI has enabled advanced applications including synthetic image generation, motion correction, and accelerated acquisition protocols [63, 64]. Generative adversarial networks (GANs) can produce high-quality images from undersampled k-space data, reducing scan times without compromising diagnostic quality [65, 66]. A deep learning approach for detecting facial nerve enhancement in Bell's palsy achieved high sensitivity and specificity, illustrating the potential for similar applications in veterinary cranial nerve disorders [150].
3.3 Ultrasound and Echocardiography
Ultrasound imaging presents unique challenges for AI analysis due to operator dependence, variable image quality, and the presence of speckle noise [67, 68]. Despite these challenges, deep learning models have been developed for automated measurement of cardiac chambers, detection of valvular abnormalities, and classification of hepatic parenchymal patterns [69, 70]. AI-augmented electrocardiography for pre-echocardiography triage has been proposed as a tool to optimize cardiac imaging utilization [96].
Machine learning models incorporating ultrasound and clinicopathological features have been developed for predicting neoadjuvant therapy efficacy [128]. The combination of B-mode imaging, Doppler parameters, and tissue characterization data provides a rich feature space for ML algorithms [71, 72]. Foundation models trained on large datasets of coronary angiograms have demonstrated the ability to screen for severe valvular disease, suggesting similar potential for veterinary cardiac imaging [3].
4. Molecular Diagnostics and Genomic Applications
4.1 Genomic Sequence Analysis
The application of AI to genomic data has revolutionized the interpretation of sequencing results in diagnostic settings [73, 74]. Variant calling pipelines increasingly incorporate ML algorithms to distinguish true genetic variants from sequencing artifacts [75, 76]. Deep learning models have been developed to predict the functional impact of missense variants, splice site alterations, and regulatory region mutations [77, 78].
Whole genome sequencing combined with AI analysis has enabled the diagnosis of rare genetic disorders that would otherwise remain undetected [45]. Machine learning approaches for variant prioritization integrate multiple data sources including evolutionary conservation, protein structure, and tissue-specific expression patterns [79, 80]. The identification of rare mitochondrial DNA variants among individuals with kidney disease has revealed undiagnosed mitochondrial disease, highlighting the diagnostic potential of AI-enhanced genomic analysis [95].
4.2 Transcriptomics and Gene Expression Profiling
Transcriptomic data generated by RNA sequencing or microarray platforms provide a snapshot of cellular gene expression patterns that can inform disease diagnosis and classification [81, 82]. Machine learning models trained on gene expression data have been developed for molecular subtyping of tumors, identification of infectious disease signatures, and prediction of treatment responses [83, 84]. Multi-omics integration frameworks combine transcriptomic data with proteomic, metabolomic, and epigenomic information to construct comprehensive diagnostic models [85, 86].
A machine learning integrated multi-omics framework has been developed for risk prediction and target discovery in sepsis-induced acute lung injury [88]. The identification of Th17 cell-associated biomarkers in chronic obstructive pulmonary disease through integrated bioinformatics analysis and machine learning demonstrates the power of these approaches for biomarker discovery [61]. Feature selection algorithms, including LASSO regression and recursive feature elimination, identify the most informative genes for diagnostic classification [87, 89].
4.3 Proteomics and Metabolomics
Proteomic and metabolomic profiling generate high-dimensional datasets that are well suited for ML analysis [90, 91]. Mass spectrometry data, including matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) spectra, can be classified using ML algorithms for microbial identification and biomarker discovery [92, 93]. An explainable prognostic prediction panel for sepsis based on serum amino acid profiles demonstrated the clinical utility of ML-enhanced metabolomic analysis [86].
Machine learning-assisted modeling of Raman spectroscopy has emerged as a powerful approach for biomedical diagnostics [136]. The combination of spectroscopic data with ML classifiers enables rapid, label-free identification of pathological tissues and infectious agents [97, 98]. Artificial olfactory colorimetric sensor arrays combined with ML analysis have been developed for early detection of bladder cancer from urinary volatile organic compounds, illustrating the potential for noninvasive diagnostic screening [137].
5. Clinical Pathology and Laboratory Diagnostics
5.1 Hematology and Clinical Chemistry
Automated hematology analyzers generate complete blood counts that include multiple parameters amenable to ML analysis [99, 100]. Machine learning models have been developed to detect abnormal cell populations, classify anemias, and predict the need for blood product transfusion [101, 102]. Deep learning approaches for peripheral blood smear analysis can identify blast cells, atypical lymphocytes, and other morphological abnormalities with high accuracy [103, 104].
Clinical chemistry data, including enzyme activities, electrolyte concentrations, and metabolite levels, can be integrated with ML algorithms to generate diagnostic predictions [105, 106]. Random forest models have been developed for the diagnosis of malignant pleural effusion based on pleural fluid analysis [107]. The combination of multiple laboratory parameters with clinical variables in ML models often outperforms traditional univariate reference interval approaches [108, 109].
5.2 Microbiology and Antimicrobial Susceptibility
AI applications in clinical microbiology include identification of microorganisms from culture characteristics, interpretation of antimicrobial susceptibility testing, and prediction of resistance mechanisms [110, 111]. Deep learning models trained on colony morphology images can identify bacterial and fungal species without the need for biochemical testing [112, 113]. The enhancement of clinical utility of AI-based antimicrobial resistance models requires careful consideration of data quality, model interpretability, and clinical validation [23].
Machine learning approaches for predicting antimicrobial resistance from genomic sequence data have achieved high accuracy for several pathogen-antibiotic combinations [114, 115]. Risk prediction models for carbapenem-resistant Pseudomonas aeruginosa infection in children demonstrate the potential for ML-guided antimicrobial stewardship [49]. These approaches can be extended to veterinary pathogens including those affecting livestock and companion animals.
5.3 Cytology and Histopathology
Digital pathology has enabled the application of deep learning to cytological and histopathological specimens [116, 117]. Convolutional neural networks can classify tissue sections, detect mitotic figures, and quantify biomarker expression with accuracy comparable to or exceeding that of pathologists [118, 119]. Comprehensive benchmarking of deep learning architectures for multiclass histopathological classification of oral epithelial lesions has identified optimal model configurations for clinical deployment [59].
Deep learning solutions providing molecular marker subtyping of breast cancer whole slide images have been developed and validated in clinical service evaluation studies [141]. The application of these technologies to veterinary oncology, including canine mammary tumors, feline injection-site sarcomas, and equine sarcoids, represents a significant opportunity [120, 121]. Histology-guided 3D virtual staining of microCT-imaged lung tissue via deep learning enables correlative imaging without destructive sectioning [133].
6. Predictive Modeling and Clinical Decision Support
6.1 Disease Risk Stratification
Machine learning models can integrate multiple risk factors to generate individualized disease probability estimates [122, 123]. These models have been developed for predicting the development of chronic diseases including diabetes mellitus, chronic kidney disease, and osteoarthritis in companion animals [124, 125]. The CanAssist Breast risk stratification system for multifocal breast cancer demonstrates how ML can guide clinical decision-making in complex diagnostic scenarios [10].
Predictive models for dengue severity, hospitalization, and mortality have been systematically reviewed, with meta-analyses demonstrating moderate to high discriminatory performance [134]. Similar approaches can be applied to veterinary infectious diseases including canine parvovirus, feline panleukopenia, and equine influenza [126, 127]. The integration of clinical, laboratory, and imaging data in ML models typically yields superior performance compared to models based on any single data modality [128, 129].
6.2 Prognostic Modeling
Prognostic models estimate the likely course and outcome of disease in individual patients [130, 131]. Machine learning approaches have been developed to predict survival times, treatment responses, and complication risks across numerous veterinary conditions [132, 133]. Personalized survival prediction in pediatric glioblastoma using a machine learning-powered web tool illustrates the potential for similar applications in veterinary neuro-oncology [114].
The identification of prognostic biomarkers through integrated transcriptomics and machine learning has identified HIF1A and GSTP1 as biomarkers for cutaneous squamous cell carcinoma [116]. Multi-algorithm machine learning combined with in silico gene knockout has revealed the diagnostic value and functional regulatory networks of ferroptosis-related genes in gastric cancer [115]. These methodological approaches are directly transferable to veterinary cancer research.
6.3 Triage and Resource Allocation
AI-based triage systems can prioritize patients based on disease severity and urgency of intervention [134, 135]. The utility of large language models to assist with emergency triage decisions has been evaluated in otolaryngology, with implications for similar applications in veterinary emergency medicine [1]. Artificial intelligence as a triage partner in breast cancer screening demonstrates how AI can optimize resource allocation in population-level screening programs [13].
Machine learning models for predicting frailty trajectories among older adults following hip surgery can inform postoperative care planning [139]. The application of these approaches to veterinary patients, including geriatric dogs and cats undergoing orthopedic procedures, could improve outcomes and resource utilization [136, 137]. AI-derived electrocardiographic age as a predictor of mortality and cardiovascular events has been validated in systematic reviews and meta-analyses [15].
7. Emerging Technologies and Methodological Advances
7.1 Explainable Artificial Intelligence
The black-box nature of many deep learning models has limited their clinical adoption, particularly in high-stakes diagnostic applications [138, 139]. Explainable AI (XAI) techniques, including saliency maps, gradient-weighted class activation mapping, and Shapley additive explanations, provide insights into model decision-making processes [140, 141]. Trustworthy and explainable AI for drug discovery has emerged as a critical research priority [14].
An explainable deep learning approach for sleep staging in sleep apnea patients from pulse oximetry signals demonstrates how interpretability can be achieved without sacrificing predictive performance [57]. Explainable machine learning on resting-state magnetoencephalography power spectra has revealed neural alterations in knee osteoarthritis, providing both diagnostic and mechanistic insights [145]. The development of clinically interpretable machine learning models for emergency surgery has highlighted the importance of feature importance analysis across clinical time points [125].
7.2 Large Language Models in Diagnostics
Large language models (LLMs) including generative pre-trained transformer architectures have demonstrated capabilities in medical knowledge retrieval, clinical reasoning, and report generation [142, 143]. The assessment of accuracy and consistency of responses from chat generative pre-trained transformer in human papillomavirus infection and protection has revealed both strengths and limitations [16]. Large language models provide accurate but potentially unsafe answers to multimodal critical care medicine board review questions, highlighting the need for careful validation [22].
A two-stage workflow for vitiligo diagnosis combining clinical characteristic classification with LLM-based report generation illustrates the potential for AI-assisted diagnostic documentation [87]. Authoritative textbook-augmented large language models for medical education have been developed and evaluated in cross-sectional studies [138]. The application of these technologies to veterinary diagnostic reporting, including radiographic interpretation and histopathology reporting, represents an active area of investigation [144, 145].
7.3 Multi-Omics Integration
The integration of data from multiple molecular layers, including genomics, transcriptomics, proteomics, metabolomics, and epigenomics, provides a comprehensive view of biological systems [146, 147]. Machine learning approaches for multi-omics integration include concatenation-based methods, kernel-based methods, and graph-based methods [148, 149]. A machine learning integrated multi-omics framework for risk prediction and target discovery in insomnia aggravated sepsis induced acute lung injury demonstrates the power of these approaches [88].
Multi-omic analysis of deep learning-derived phenotypes has linked ophthalmic imaging to cardiovascular and neurological traits, revealing cross-organ system relationships [121]. The integration of radiomics with genomic data, termed radiogenomics, has shown promise for noninvasive characterization of tumor molecular profiles [37]. Optimal gene panel selection for targeted spatial transcriptomics experiments can be guided by ML algorithms that maximize information content while minimizing sequencing costs [29].
8. Challenges and Limitations
8.1 Data Quality and Standardization
The performance of AI diagnostic models is fundamentally limited by the quality and representativeness of training data [150]. Variability in image acquisition protocols, laboratory methods, and clinical documentation across institutions can reduce model generalizability [1, 2]. Standardization of data collection and annotation practices is essential for the development of robust diagnostic AI systems [3, 4].
Class imbalance, where certain disease conditions are rare in the training population, can lead to models with poor sensitivity for important diagnoses [5, 6]. Techniques including data augmentation, synthetic minority oversampling, and cost-sensitive learning can partially mitigate these effects [7, 8]. The development of large, well-annotated, publicly available veterinary datasets remains a critical priority for the field [9, 10].
8.2 Validation and Regulatory Considerations
Rigorous validation of AI diagnostic models requires evaluation across diverse populations, clinical settings, and time periods [11, 12]. Prospective clinical studies provide the strongest evidence of clinical utility, but are resource-intensive and logistically challenging [13, 14]. The development of standardized reporting guidelines for AI diagnostic studies, including the STARD-AI and TRIPOD-AI checklists, aims to improve study quality and reproducibility [15, 16].
Regulatory frameworks for AI-based medical devices are evolving rapidly, with agencies developing specific guidance for software as a medical device [17, 18]. The classification of AI diagnostic tools based on risk level determines the stringency of premarket review requirements [19, 20]. Veterinary diagnostic AI applications may face different regulatory pathways depending on whether they are marketed as medical devices, laboratory-developed tests, or decision support tools [21, 22].
8.3 Ethical and Equity Considerations
The deployment of AI diagnostic tools raises important ethical considerations regarding transparency, accountability, and fairness [23, 24]. Algorithmic bias, where models perform differently across demographic groups, can perpetuate or exacerbate existing health disparities [25, 26]. The dual-use potential of AI in biology, where diagnostic technologies could be misapplied, requires careful risk-benefit review [80].
The impact of artificial intelligence and work digitalization on mental health and occupational well-being has been examined in scoping reviews [77]. Between fear and adoption, the AI paradox in medico-legal practice among insurance physicians highlights the tension between technological promise and practical implementation [9]. Disclosure of AI involvement in diagnostic processes and intellectual ownership of AI-generated insights remain unresolved legal and ethical questions [51].
9. Future Directions
9.1 Point-of-Care and Mobile Diagnostics
The integration of AI with portable diagnostic devices enables real-time analysis at the point of care [27, 28]. Smartphone-based platforms combined with ML algorithms can analyze images from otoscopes, ophthalmoscopes, and dermatoscopes for field diagnosis [29, 30]. The development of lightweight vision models for healthcare AI enables deployment on resource-constrained devices [66].
Wearable flexible sensors for disease monitoring generate continuous physiological data streams that can be analyzed by ML algorithms [102]. The combination of sensor data with AI analysis enables early detection of disease onset and progression [31, 32]. Point-of-care molecular diagnostics for feline upper respiratory pathogens can be enhanced with AI-based interpretation of results.
9.2 Federated Learning and Privacy-Preserving AI
Federated learning enables the training of AI models across multiple institutions without sharing raw patient data [33, 34]. This approach addresses privacy concerns while allowing models to benefit from diverse, large-scale datasets [35, 36]. Differential privacy techniques add calibrated noise to training processes to prevent reconstruction of individual patient information [37, 38].
The implementation of federated learning in veterinary diagnostic networks could enable the development of robust models while respecting data ownership and confidentiality [39, 40]. Secure multi-party computation and homomorphic encryption provide additional layers of privacy protection for sensitive diagnostic data [41, 42]. These technologies are particularly relevant for veterinary applications involving valuable genetic resources or notifiable disease surveillance.
9.3 Continuous Learning and Model Updating
Diagnostic AI models must be updated over time to maintain performance in the face of changing disease epidemiology, evolving laboratory methods, and population shifts [43, 44]. Continuous learning approaches allow models to incorporate new data without full retraining [45, 46]. Online learning algorithms update model parameters incrementally as new labeled samples become available [47, 48].
The detection of dataset shift, where the distribution of new data differs from training data, is essential for maintaining model reliability [49, 50]. Monitoring systems that track model performance metrics over time can trigger alerts when retraining is needed [51, 52]. The development of automated quality assurance pipelines for veterinary diagnostic AI systems will be critical for long-term deployment success.
10. Conclusion
Artificial intelligence and machine learning have demonstrated transformative potential across the full spectrum of veterinary diagnostics, from imaging and clinical pathology to molecular diagnostics and predictive modeling. The biophysical and algorithmic principles underlying these technologies are well established, and their clinical applications continue to expand rapidly. However, realizing the full potential of AI in veterinary diagnostics requires addressing significant challenges related to data quality, validation rigor, regulatory clarity, and ethical implementation. The integration of AI tools into routine veterinary practice, guided by evidence-based evaluation and clinical expertise, promises to enhance diagnostic accuracy, improve patient outcomes, and advance the field of veterinary medicine.
Workflow Diagram
flowchart TD
A[Clinical Presentation] --> B[Diagnostic Data Acquisition]
B --> C[Imaging Data]
B --> D[Laboratory Data]
B --> E[Genomic Data]
B --> F[Clinical Parameters]
C --> G[Preprocessing and Feature Extraction]
D --> G
E --> G
F --> G
G --> H[Machine Learning Model]
H --> I[Model Training and Validation]
I --> J[Performance Evaluation]
J --> K{Acceptable Performance?}
K -->|Yes| L[Clinical Deployment]
K -->|No| M[Model Refinement]
M --> G
L --> N[Diagnostic Output]
N --> O[Clinician Review]
O --> P[Final Diagnosis]
P --> Q[Treatment Decision]
L --> R[Continuous Monitoring]
R --> S{Performance Drift Detected?}
S -->|Yes| M
S -->|No| R
References
[1] Hack S, Attal R, Steckbeck RJ et al. The Utility of Large Language Models to Assist With Emergency Triage Decisions Within Otolaryngology. Otolaryngol Head Neck Surg. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307998/
[2] Guo Y. Retraction Note: Examining the Impact of Assistive Technology on Psychological Health, Family Education, and Curriculum Research in Japan: Insights from Artificial Intelligence. J Autism Dev Disord. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307882/
[3] Zhang Y, Shao Z, Wei Z et al. Foundation model for screening severe mitral regurgitation and severe aortic stenosis from coronary angiograms. Vis Comput Ind Biomed Art. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307866/
[4] Akram S. Embryo transfer in dairy herds: a comprehensive review of factors affecting pregnancy success from donor to embryo and recipient. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307812/
[5] Lach-Gruba A, Turczyn P, Brodacki S et al. Virtual reality in shoulder rehabilitation and shoulder arthroplasty pathways: a narrative review of current evidence and clinical perspectives. Rheumatol Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307800/
[6] Chen JG, Zhao Y, Koh TS et al. The effect of excess body weight on short-term outcomes following minimally invasive rectal cancer surgery: a systematic review and meta-analysis. Tech Coloproctol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307793/
[7] Zhou C, Zhang Y, Fu S et al. Mechanistic study of annular eccentricity-induced flow instability and thrombus growth in TAVI patients: a geometric sensitivity analysis. Biomech Model Mechanobiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307790/
[8] Park JH, Cho C, Kim HS et al. Development of an Arterial Carbon Dioxide Estimation Model Using End-Tidal Carbon Dioxide Levels during Surgery in the Pediatric Population. Anesthesiology. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307593/
[9] Ellenberg E, Amsalem D, Katorza E. Between Fear and Adoption: The AI Paradox in Medico-Legal Practice Among National Insurance Physicians. J Insur Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307554/
[10] Savitha BA, Durgekar TD, Shrivastava P et al. CanAssist Breast Risk Stratification in Multifocal/Multicentric Breast Cancer: To Test Each Focus or Not? Arch Pathol Lab Med. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307550/
[11] Andreaggi S, Scalamera R, Kim S et al. Integrated Coronary CT Angiography Assessment of Plaque Vulnerability and Clinical Outcomes: The Morphology-Inflammation-Burden (MIB) Score. JACC Cardiovasc Imaging. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307514/
[12] Akshintala VS, Chak A, Chen YI et al. Innovation and commercialization pathway in gastrointestinal endoscopy: a practical primer from American Society for Gastrointestinal Endoscopy. Gastrointest Endosc. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307510/
[13] Yao MS, Chae A. Artificial Intelligence as a Triage Partner in Breast Cancer Screening. Radiol Artif Intell. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307447/
[14] Steigele S. Trustworthy and explainable AI for drug discovery. Expert Opin Drug Discov. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307433/
[15] Bozzi ICRS, Lima MCAG, Ribeiro ALP et al. Artificial Intelligence-Derived ECG-Age as a Predictor of Mortality and Cardiovascular Events: A Systematic Review and Meta-Analysis. Arq Bras Cardiol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42307380/
Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.